Cargando…

OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial

Obesity reduces fertility and the effectiveness of fertility treatments in women, in addition to increasing pregnancy complications and programming of childhood obesity. Since studies have suggested that weight loss and lifestyle management could improve the fertility of women with obesity, obesity...

Descripción completa

Detalles Bibliográficos
Autores principales: Belan, Matea, Carranza-Mamane, Belina, Ainmelk, Youssef, Pesant, Marie-Helene, Duval, Karine, Jean-Denis, Farrah, Langlois, Marie-France, Baillargeon, Jean-Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554757/
http://dx.doi.org/10.1210/js.2019-OR11-2
_version_ 1783425012061962240
author Belan, Matea
Carranza-Mamane, Belina
Ainmelk, Youssef
Pesant, Marie-Helene
Duval, Karine
Jean-Denis, Farrah
Langlois, Marie-France
Baillargeon, Jean-Patrice
author_facet Belan, Matea
Carranza-Mamane, Belina
Ainmelk, Youssef
Pesant, Marie-Helene
Duval, Karine
Jean-Denis, Farrah
Langlois, Marie-France
Baillargeon, Jean-Patrice
author_sort Belan, Matea
collection PubMed
description Obesity reduces fertility and the effectiveness of fertility treatments in women, in addition to increasing pregnancy complications and programming of childhood obesity. Since studies have suggested that weight loss and lifestyle management could improve the fertility of women with obesity, obesity management with lifestyle modification is recommended for these women. Objectives: To evaluate the impacts of a lifestyle program in women with obesity and infertility on: 1) fertility outcomes, and 2) anthropometric and lifestyle measures. Methods: Women with obesity and infertility consulting at the fertility clinic of an academic hospital were randomized to the lifestyle program group (LPG) or control group (CG). Women in the CG began usual fertility care directly. Those in the LPG received the lifestyle intervention alone, without fertility treatments, for the first 6 months, and then in association with fertility treatments, if not pregnant. The lifestyle intervention combined individual and group sessions with a nutritionist and a kinesiologist in order to support progressive and sustainable lifestyle modifications. Per-protocol analyses including women who completed at least 6 months of the trial, or became pregnant, are presented. The maximal duration of follow-up, and intervention in the LPG, was 18 months or the end of pregnancy. Proportions were compared using chi-squared tests and means, using Student’s t tests. Results: Among 130 randomized women, 108 completed at least 6 months of the study or became pregnant (83%, 51 LPG and 57 CG). In these women, the lifestyle program increased by 58% the pregnancy rate as compared to controls (60.8% vs 38.6%, p=0.021) and almost tripled the proportion of women who conceived spontaneously, without fertility treatments (33.3% vs 12.3%, p=0.009). The lifestyle program also increased the live birth rate by 39% (51.0% vs 36.8%), although this was not statistically significant (p=0.139). When comparing participants with measures at 6 months of follow-up or at first pregnancy visit if before 6 months (75%, 46 LPG; 51 CG), women in the LPG lost significantly more % of weight (-3.4 ± 4.5% vs -0.89 ± 3.7, p=0.003), waist circumference (-2.9 ± 4.3 cm vs -0.97 ± 4.4, p=0.036) and % of fat mass (-1.3 ± 2.1% vs -0.47 ± 1.3%, p=0.033) compared to the CG. They also improved significantly more their lifestyle habits than the CG (healthy eating index: +18.2 ± 13.7 points vs +5.3 ± 12.4, p<0.001; total leisure activity’s energy expenditure: +0.77 ± 1.63 kcal/kg/day vs +0.17 ± 1.26 kcal/kg/day, p=0.044). Conclusion: A lifestyle program targeting women with obesity seeking fertility treatments improves not only their anthropometry and lifestyle habits, but most importantly, their chances of conceiving, especially spontaneously, in comparison to standard fertility treatments alone. Such impact could significantly reduce the costs associated with fertility treatments. Unless otherwise noted, all abstracts presented at ENDO are embargoed until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.
format Online
Article
Text
id pubmed-6554757
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65547572019-06-13 OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial Belan, Matea Carranza-Mamane, Belina Ainmelk, Youssef Pesant, Marie-Helene Duval, Karine Jean-Denis, Farrah Langlois, Marie-France Baillargeon, Jean-Patrice J Endocr Soc Reproductive Endocrinology Obesity reduces fertility and the effectiveness of fertility treatments in women, in addition to increasing pregnancy complications and programming of childhood obesity. Since studies have suggested that weight loss and lifestyle management could improve the fertility of women with obesity, obesity management with lifestyle modification is recommended for these women. Objectives: To evaluate the impacts of a lifestyle program in women with obesity and infertility on: 1) fertility outcomes, and 2) anthropometric and lifestyle measures. Methods: Women with obesity and infertility consulting at the fertility clinic of an academic hospital were randomized to the lifestyle program group (LPG) or control group (CG). Women in the CG began usual fertility care directly. Those in the LPG received the lifestyle intervention alone, without fertility treatments, for the first 6 months, and then in association with fertility treatments, if not pregnant. The lifestyle intervention combined individual and group sessions with a nutritionist and a kinesiologist in order to support progressive and sustainable lifestyle modifications. Per-protocol analyses including women who completed at least 6 months of the trial, or became pregnant, are presented. The maximal duration of follow-up, and intervention in the LPG, was 18 months or the end of pregnancy. Proportions were compared using chi-squared tests and means, using Student’s t tests. Results: Among 130 randomized women, 108 completed at least 6 months of the study or became pregnant (83%, 51 LPG and 57 CG). In these women, the lifestyle program increased by 58% the pregnancy rate as compared to controls (60.8% vs 38.6%, p=0.021) and almost tripled the proportion of women who conceived spontaneously, without fertility treatments (33.3% vs 12.3%, p=0.009). The lifestyle program also increased the live birth rate by 39% (51.0% vs 36.8%), although this was not statistically significant (p=0.139). When comparing participants with measures at 6 months of follow-up or at first pregnancy visit if before 6 months (75%, 46 LPG; 51 CG), women in the LPG lost significantly more % of weight (-3.4 ± 4.5% vs -0.89 ± 3.7, p=0.003), waist circumference (-2.9 ± 4.3 cm vs -0.97 ± 4.4, p=0.036) and % of fat mass (-1.3 ± 2.1% vs -0.47 ± 1.3%, p=0.033) compared to the CG. They also improved significantly more their lifestyle habits than the CG (healthy eating index: +18.2 ± 13.7 points vs +5.3 ± 12.4, p<0.001; total leisure activity’s energy expenditure: +0.77 ± 1.63 kcal/kg/day vs +0.17 ± 1.26 kcal/kg/day, p=0.044). Conclusion: A lifestyle program targeting women with obesity seeking fertility treatments improves not only their anthropometry and lifestyle habits, but most importantly, their chances of conceiving, especially spontaneously, in comparison to standard fertility treatments alone. Such impact could significantly reduce the costs associated with fertility treatments. Unless otherwise noted, all abstracts presented at ENDO are embargoed until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO. Endocrine Society 2019-04-30 /pmc/articles/PMC6554757/ http://dx.doi.org/10.1210/js.2019-OR11-2 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Reproductive Endocrinology
Belan, Matea
Carranza-Mamane, Belina
Ainmelk, Youssef
Pesant, Marie-Helene
Duval, Karine
Jean-Denis, Farrah
Langlois, Marie-France
Baillargeon, Jean-Patrice
OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial
title OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial
title_full OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial
title_fullStr OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial
title_full_unstemmed OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial
title_short OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial
title_sort or11-2 a lifestyle program targeting women with obesity and infertility improves their fertility: a randomized controlled trial
topic Reproductive Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554757/
http://dx.doi.org/10.1210/js.2019-OR11-2
work_keys_str_mv AT belanmatea or112alifestyleprogramtargetingwomenwithobesityandinfertilityimprovestheirfertilityarandomizedcontrolledtrial
AT carranzamamanebelina or112alifestyleprogramtargetingwomenwithobesityandinfertilityimprovestheirfertilityarandomizedcontrolledtrial
AT ainmelkyoussef or112alifestyleprogramtargetingwomenwithobesityandinfertilityimprovestheirfertilityarandomizedcontrolledtrial
AT pesantmariehelene or112alifestyleprogramtargetingwomenwithobesityandinfertilityimprovestheirfertilityarandomizedcontrolledtrial
AT duvalkarine or112alifestyleprogramtargetingwomenwithobesityandinfertilityimprovestheirfertilityarandomizedcontrolledtrial
AT jeandenisfarrah or112alifestyleprogramtargetingwomenwithobesityandinfertilityimprovestheirfertilityarandomizedcontrolledtrial
AT langloismariefrance or112alifestyleprogramtargetingwomenwithobesityandinfertilityimprovestheirfertilityarandomizedcontrolledtrial
AT baillargeonjeanpatrice or112alifestyleprogramtargetingwomenwithobesityandinfertilityimprovestheirfertilityarandomizedcontrolledtrial